You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Cizzle Biotechnology Secures US Patent to Advance Lung Cancer Diagnostic Technology Cizzle Biotechnology has been granted a key US patent covering its lung cancer detection technology, specifically related to the CIZ1B biomarker. This patent enhances the company’s IP protection in a critical healthcare... Read the full IIPLA article: https://iipla.org/news/cizzle-biotechnology-secures-us-patent-to-advance-lung-cancer-diagnostic-technology